Here’s what you should know.
1. Allergan reported earnings per share of $3.90 for its fourth quarter, beating analysts’ estimates of $3.76 EPS.
2. The company’s $3.86 billion in revenues for Q4 also exceeded analysts’ expectations of $3.77 billion.
3. Allergan’s stock opened at $245.68 on Feb. 10, 2017.
4. The company’s 52-week high is $301.32 and 52-week low is $184.50.
More articles on gastroenterology/endoscopy:
GI leader to know: Dr. Warren Butt of Gastroenterology Associates
Drs. Glenn Eisen, David Carr-Locke & more — 4 GI physicians in the headlines
Column: Can frozen stool replace fresh in fecal transplants? 5 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.